Arbitration for life sciences companies
von mehreren Autoren
Legal advice privilege: where are we now?
von Georgina Jones
Patents diary June 2020: UK Supreme Court holds Regeneron's transgenic mice patents invalid
von Dr Paul England
Territorial licensing: "start at the end before you begin"
von Colin McCall und Justyna Ostrowska
Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow
von Adrian Toutoungi und Josef Fuss
Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues
von Adrian Toutoungi und Josef Fuss
A missed chance
von Dr. Anja Lunze, LL.M. und Verena Bertram
NHS can procure drugs for use outside of their approved indications if it's cheaper, court says